Search Results for: SRC

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
TXK TXK tyrosine kinase
  • FCERI mediated Ca+2 mobilization
  • FCERI mediated Ca+2 mobilization
  • Fostamatinib
  • Zanubrutinib
YWHAB tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta
  • Activation of BAD and translocation to mitochondria
  • Translocation of SLC2A4 (GLUT4) to the plasma membrane
  • MTOR signalling
  • mTORC1-mediated signalling
  • Frs2-mediated activation
  • Frs2-mediated activation
  • ARMS-mediated activation
  • Signaling by Hippo
  • Rap1 signalling
  • Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA
  • Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA
  • RHO GTPases activate PKNs
  • TP53 Regulates Metabolic Genes
  • RAF activation
  • MAP2K and MAPK activation
  • Negative regulation of MAPK pathway
  • Signaling by moderate kinase activity BRAF mutants
  • Signaling by high-kinase activity BRAF mutants
  • Signaling by BRAF and RAF fusions
  • Paradoxical activation of RAF signaling by kinase inactive BRAF
  • Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex
  • Regulation of localization of FOXO transcription factors
  • Signaling downstream of RAS mutants
  • Signaling by RAF1 mutants
  • Signaling by MRAS-complex mutants
  • Copper
  • Phenethyl Isothiocyanate
YWHAE tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon
  • Activation of BAD and translocation to mitochondria
  • Translocation of SLC2A4 (GLUT4) to the plasma membrane
  • Signaling by Hippo
  • NADE modulates death signalling
  • Regulation of PLK1 Activity at G2/M Transition
  • Regulation of HSF1-mediated heat shock response
  • HSF1 activation
  • Loss of Nlp from mitotic centrosomes
  • Recruitment of mitotic centrosome proteins and complexes
  • Loss of proteins required for interphase microtubule organization from the centrosome
  • Recruitment of NuMA to mitotic centrosomes
  • Anchoring of the basal body to the plasma membrane
  • RHO GTPases activate PKNs
  • TP53 Regulates Metabolic Genes
  • Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex
  • AURKA Activation by TPX2
  • Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
  • RAB GEFs exchange GTP for GDP on RABs
  • Fusicoccin
  • Phenethyl Isothiocyanate
  • Lissencephaly (LIS); Miller-Dieker syndrome (MDLS)
BAAT bile acid-CoA:amino acid N-acyltransferase
  • Recycling of bile acids and salts
  • Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol
  • Peroxisomal protein import
  • Peroxisomal protein import
  • Glycine
  • Peroxisomal beta-oxidation enzyme deficiency, including: Acyl-CoA oxidase (ACOX) deficiency; D-bifunctional protein (DBP) deficiency; Perrault syndrome; Sterol carrier protein X (SCPx) deficiency; 2-Methylacyl-CoA racemase (AMCR) deficiency; Hypercholanemia
CEACAM1 CEA cell adhesion molecule 1
  • Fibronectin matrix formation
  • Cell surface interactions at the vascular wall
  • Neutrophil degranulation
  • Technetium Tc-99m arcitumomab
CTNNB1 catenin beta 1
  • Degradation of beta-catenin by the destruction complex
  • Beta-catenin phosphorylation cascade
  • TCF dependent signaling in response to WNT
  • Formation of the beta-catenin:TCF transactivating complex
  • Formation of the beta-catenin:TCF transactivating complex
  • LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production
  • Apoptotic cleavage of cell adhesion proteins
  • Deactivation of the beta-catenin transactivating complex
  • Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)
  • Ca2+ pathway
  • Adherens junctions interactions
  • Binding of TCF/LEF:CTNNB1 to target gene promoters
  • Disassembly of the destruction complex and recruitment of AXIN to the membrane
  • Disassembly of the destruction complex and recruitment of AXIN to the membrane
  • VEGFR2 mediated vascular permeability
  • Myogenesis
  • Myogenesis
  • Signaling by GSK3beta mutants
  • S33 mutants of beta-catenin aren't phosphorylated
  • S37 mutants of beta-catenin aren't phosphorylated
  • S45 mutants of beta-catenin aren't phosphorylated
  • T41 mutants of beta-catenin aren't phosphorylated
  • RHO GTPases activate IQGAPs
  • Transcriptional Regulation by VENTX
  • InlA-mediated entry of Listeria monocytogenes into host cells
  • RUNX3 regulates WNT signaling
  • Urea
  • Gastric cancer
  • Colorectal cancer
  • Endometrial Cancer
  • Pilomatricoma; Epithelioma calcificans of Malherbe
  • Thyroid cancer
  • Hepatocellular carcinoma
DAPP1 dual adaptor of phosphotyrosine and 3-phosphoinositides 1
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • Inositol 1,3,4,5-Tetrakisphosphate
DGKZ diacylglycerol kinase zeta
  • Effects of PIP2 hydrolysis
  • alpha-Tocopherol succinate
EPHA3 EPH receptor A3
  • EPH-Ephrin signaling
  • EPH-Ephrin signaling
  • EPHA-mediated growth cone collapse
  • EPHA-mediated growth cone collapse
  • EPH-ephrin mediated repulsion of cells
  • EPH-ephrin mediated repulsion of cells
  • Fostamatinib
EPHA4 EPH receptor A4
  • EPH-Ephrin signaling
  • EPH-Ephrin signaling
  • EPHA-mediated growth cone collapse
  • EPHA-mediated growth cone collapse
  • EPH-ephrin mediated repulsion of cells
  • EPH-ephrin mediated repulsion of cells
  • Fostamatinib
ERBB3 erb-b2 receptor tyrosine kinase 3
  • Tucatinib
  • Lethal congenital contractural syndrome (LCCS)
  • Type I diabetes mellitus
FLNA filamin A
  • Platelet degranulation
  • GP1b-IX-V activation signalling
  • Cell-extracellular matrix interactions
  • RHO GTPases activate PAKs
  • OAS antiviral response
  • Artenimol
  • Syndromic X-linked mental retardation with epilepsy or seizures, including: West syndrome (WS); Partington syndrome (PRTS); Proud syndrome (ACCAG); XMR and epilepsy (XMRE); MRXHF1; XMR OPHN1-related (MRXSO) ; XELBD; XMR, Christianson type (MRXSC); Creatine deficiency syndrome (XL-CDS); Renpenning syndrome (RENS1); Epilepsy and mental retardation limited to females (EFMR); Periventricular nodular heterotopia (PVNH); Hydrocephalus (XLH); XMR, JARID1C related (MRXSJ); Boerjeson-Forssman syndrome (BFLS); CK syndrome (CKS)
  • Fronto-Otopalatodigital Osteodysplasia, including: Otopalatodigital syndrome, type I; Otopalatodigital syndrome, type II; Melnick-Needles syndrome; Frontometaphyseal dysplasia
  • Periventricular nodular heterotopia (PVNH)
  • FG syndrome (FGS); Opitz-Kaveggia syndrome
GJA1 gap junction protein alpha 1
  • Oligomerization of connexins into connexons
  • Transport of connexins along the secretory pathway
  • Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane
  • Gap junction assembly
  • Gap junction assembly
  • Gap junction degradation
  • Regulation of gap junction activity
  • Regulation of gap junction activity
  • Formation of annular gap junctions
  • Carvedilol
  • Syndactyly
  • Deafness, autosomal recessive
  • Oculodentodigital dysplasia
GRK2 G protein-coupled receptor kinase 2
  • Calmodulin induced events
  • G alpha (q) signalling events
  • G alpha (s) signalling events
  • Activation of SMO
  • Activation of SMO
  • Cargo recognition for clathrin-mediated endocytosis
  • ATP
GUCY2C guanylate cyclase 2C
  • Digestion
  • Intestinal infectious diseases
  • Linaclotide
HNF1A HNF1 homeobox A
  • Regulation of gene expression in beta cells
  • D-norleucine
  • Maturity onset diabetes of the young (MODY)
MATK megakaryocyte-associated tyrosine kinase
  • Downregulation of ERBB2 signaling
  • Fostamatinib
MST1R macrophage stimulating 1 receptor
  • Signaling by MST1
  • Fostamatinib
MT-ND2 NADH dehydrogenase subunit 2
  • Respiratory electron transport
  • Complex I biogenesis
  • NADH
  • Leber optic atrophy; Leber hereditary optic atrophy (LHON)
MUC1 mucin 1, cell surface associated
  • Defective GALNT3 causes familial hyperphosphatemic tumoral calcinosis (HFTC)
  • Defective C1GALT1C1 causes Tn polyagglutination syndrome (TNPS)
  • Defective GALNT12 causes colorectal cancer 1 (CRCS1)
  • Dectin-2 family
  • Interleukin-4 and Interleukin-13 signaling
  • O-linked glycosylation of mucins
  • Termination of O-glycan biosynthesis
  • TG4010

Page 7 out of 16 pages